Smell No Evil

Risk Management; New YorkVol. 56 Nbr. 6, July 2009

Linked as:

Summary


The makers of the popular Zicam line of homeopathic cold remedies were forced to pull their nasal sprays and gel swabs from store shelves in June after the Food and Drug Administration (FDA) warned that using the products could result in the permanent loss of the sense of smell. The FDA took action after receiving more than 130 reports from consumers who had lost their senses of smell after using the products. Zicam's manufacturer Matrixx Initiatives Inc had also received more than 800 similar reports. In addition, the FDA will now require Matrixx to formally seek its approval before bringing the products back to market -- a process that may cost the company more time and money than it is willing or able to spend.

See the full content of this document

Extract


Smell No Evil

The makers of the popular Zicam line of homeopathic cold remedies were forced to pull their nasal sprays and gel swabs from store shelves in June a...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company